Super-Pulsed Thulium Fiber Laser Versus Holmium:YAG Laser in Retrograde Intrarenal Surgery for Upper Ureteral and Renal Stones

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorSun Yat-Sen Memorial Hospital of Sun Yat-Sen University

About this trial

The holmium laser is currently considered the gold standard for lithotripsy on urinary lithiasis, whereas the super-pulsed thulium fibre laser is a relatively new technology. Through a multi-center prospective randomised clinical study that mainly aims to explore the effectiveness and safety of a super-pulsed fibre thulium laser compared to a holmium laser in the treatment of upper ureteral and renal stones (10mm\<cumulative maximum diameter ≤ 25mm) in retrograde intrarenal surgery. The research participants are assigned randomly to undergo retrograde intrarenal surgery (RIRS) either using a super-pulsed thulium fibre laser or a holmium-YAG laser with an allocation ratio of 1:1. The secondary aim of this study is to provide high-level evidence for the development of diagnostic and treatment guidelines in the field of urolithiasis, both domestically and internationally. The outcomes of the RIRS procedures are compared for the two treatment arms.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

18 ≤ Age ≤ 75 years old, regardless of gender, able to tolerate surgery;

Patients who have been confirmed by bilateral renal/urinary tract CT to have upper ureteral or renal stones, single or multiple, and are planning to undergo ureteroscopic lithotripsy for stone removal;

Confirmed by bilateral renal/urinary tract CT, the cumulative maximum diameter of stones is 10mm<cumulative maximum diameter ≤ 25mm;

Those who voluntarily participate and sign an informed consent form.

Disqualifiers

Uncontrollable systemic hemorrhagic disease;

Severe spinal deformities, severe hip joint deformities, and difficulty in lithotomy position;

Uncontrolled urinary tract infections;

Any intracavitary surgery caused by anatomical factors of the urinary system cannot be performed;

Trial design

Design model

Parallel

Treatments tested in this trial

  • Superpulse Thulium Fiber laser (SPTFL) ureteroscopy for treatment of upper urinary tract stone or renal stone

    Device

    RIRS procedure for upper ureteral or renal stone lithotripsy with Superpulsed Thulium Laser

  • Holmium: YAG laser ureteroscopy for treatment of upper urinary tract stone or renal stone

    Device

    RIRS procedure for upper ureteral or renal stone lithotripsy with Holmium: YAG Laser

Treatment groups

448 Participants
are divided into 2 treatment groups
Group A: Superpulse Thulium Fiber laser (SPTFL)Active comparator 1 intervention
Group B: Holmium: YAG laserActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Stone-Free Rate at 4 Weeks Postoperative (Percentage of Participants)

Urinary tract CT(Computed Tomography)scan at 4 weeks post-operative did not reveal residual stones or residual stones with a diameter ≤ 2 mm and no clinical symptoms were defined as stone clearance

Time frame
4 week post-operative

Secondary outcomes

1

Intraoperative complication rate (Percentage of Participants)

Includes ureteral or renal pelvis perforation, mucosal avulsion, ureteral rupture, conversion to other treatments, and success rate of ureteral access sheath insertion.

Time frame
During the procedure
2

Change in Hemoglobin from Baseline (g/dL)

Hemoglobin measured before and within 24 hours after surgery

Time frame
Within 24 hours postoperative
3

Change in Serum Creatinine from Baseline (μmol/L)

Serum creatinine measured before and within 24 hours after surgery

Time frame
Within 24 hours postoperative
4

Change in Blood Urea Nitrogen from Baseline (mmol/L)

BUN measured before and within 24 hours after surgery

Time frame
Within 24 hours postoperative

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Lead sponsor

RenJi Hospital

Collaborator

Tongji Hospital

Collaborator

West China Hospital

Collaborator

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Collaborator

Renmin Hospital of Wuhan University

Collaborator

Beijing Friendship Hospital

Collaborator

Second Affiliated Hospital of Guangzhou Medical University

Collaborator

Beijing Tsinghua Changgeng Hospital

Collaborator

People's Hospital of Guangxi Zhuang Autonomous Region

Collaborator

Peking University Shenzhen Hospital

Collaborator

Shenzhen People's Hospital

Collaborator

This trial is not recruiting at the moment. You can still explore other options: